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In this study we asked whether Helicobacter pylori whole cells and lipopolysaccharide (LPS) utilize sugar moieties of Lewis (Le)
antigenic determinants to interact with DC-SIGN (dendritic cell speciﬁc ICAM grabbing nonintegrin) receptor on dendritic cells
(DCs). For this purpose the soluble DC-SIGN/Fc adhesion assay and the THP-1 leukemia cells with induced expression of DC-
SIGN were used. We showed that the binding speciﬁcity of DC-SIGN with H. pylori LeX/Y positive whole cells and H. pylori LPS
of LeX/Y type was fucose dependent, whereas in LeXY negative H. pylori strains and LPS preparations without Lewis determinants,
this binding was galactose dependent. The binding of soluble synthetic LeX and LeY to the DC-SIGN-like receptor on THP-1 cells
was also observed. In conclusion, the LeXY dependent as well as independent binding of H. pylori whole cells and H. pylori LPS
to DC-SIGN was described. Moreover, we demonstrated that THP-1 cells may serve as an in vitro model for the assessment of H.
pylori—DC-SIGN interactions mediated by LeX and LeY determinants.
1.Introduction
Helicobacter pylori is a causative agent of chronic gastritis,
gastroduodenal ulcers, and gastric cancers. The correlation
between H. pylori-infection and gastroduodenal diseases was
described in 1983 by Marshall and Warren [1]. The course
of H. pylori infection depends on the host immune responses
towards this pathogen, both innate and adaptive. In H. pylori
infected individuals the gastric mucosa is massively inﬁl-
trated with immunocompetent cells, which interact in a
complex way with bacterial cells. Such interactions are res-
ponsible for gastric pathologies but they are also involved in
the elimination of these pathogens from the gastric mucosa
[2]. During the ﬁrst stages of the infection various H. pylori
compounds, for example, urease, vacuolating cytotoxin-
VacA, or cytotoxin associated gene A antigen (CagA), initiate
an acute inﬂammatory response in the gastric epithelium,
which later becomes chronic [3–5]. Long-lasting inﬂamma-
tion results in many pathological disorders in the mucus
layer and diminished ability of the immune cells to ﬁght the
infection [6–10].
Although a lipopolysaccharide (LPS) is an important
proinﬂammatory compound of gram-negative bacteria [11],
the structure of H. pylori lipid A probably evolved in the
mode which promoted persistence of the infection. It was
shown that H. pylori LPS regulates the expression of adhesins
and it can diminish the secretion of inﬂammatory cytokines
by host immune cells [12]. Recently, antiphagocytic and
antiproliferative properties of H. pylori L P Sw e r ea l s od e -
tected [13, 14]. Downregulation of the natural cytotoxic
capacity of lymphocytes in response to H. pylori LPS was
correlatedwiththemodulationofIFN-γ,interleukin2(IL-2)
and IL-10 secretion by the immune cells [15]. It was sug-
gested that H. pylori LPS, through the activation of immuno-
competent cells diminish the number of bacteria in the
gastric tissue and thus prolong the infection [16].
The majority of H. pylori strains produce LPS with Lewis
(Le) blood group antigens in O-speciﬁc chains: LeX,L e Y,2 Journal of Biomedicine and Biotechnology
Ht y p e1 ,L e a,L e b, i-antigen, and sialyl LeX [17–22]. The
sugar residues in the O-speciﬁc chains, which are similar to
Ledeterminantsofthehost,inﬂuencetheactivityofH.pylori
LPS.TheexpressionofLedeterminantsbyH.pyloriresultsin
better attachment of the bacteria to the host epithelial cells,
modulation of the inﬂammatory response, and evasion of
the bacteria due to mimicking blood group antigens present
on the gastric mucosa [23, 24]. The epitope mimicry may
contribute to the pathological, autoreactive responses during
H. pylori infections [25, 26]. The Lewis expression on H.
pyloricellsiscloselyrelatedtotheepithelialareaandthestage
of disease [27].
The interactions of LPS with host cells are mediated by
both,cellularand solublemoleculesinvolved incellsignaling
via Toll-like receptor 4 (TLR 4) [28–30]. Analyses of the
interactions between puriﬁed H. pylori LPS and TLRs re-
vealed that, in contrast to LPSs from other gram-negative
bacteria, the LPS of H. pylori is not eﬀectively recognized
by TLR4. The localization of TLRs on the basolateral poles
of epithelial cells reduces the likelihood of H. pylori being
recognized by these receptors [31, 32]. However, it was sug-
gested that the phase-variable expression of Lewis antigens
allows the bacteria to modulate the host adaptive immune
response through interactions with DC-SIGN (dendritic
cell-speciﬁc ICAM-grabbing nonintegrin) on dendritic cells
(DCs) and macrophage subpopulations [33]. DCs are highly
specialized antigen-presenting cells, capable of activating
naive and memory T lymphocytes. A number of adhesive or
cytokine receptor-mediated interactions between DCs and T
lymphocytes are important for proper T lymphocyte activa-
tion [34]. DC-SIGN is a C-type lectin representing calcium-
dependent carbohydrate binding molecules. DCs expressing
the DC-SIGN receptor are present on all mucosal surfaces
and lymphoid organs. Although no antigenic stimulation is
required to induce the expression of DC-SIGN on DCs, ma-
crophages need an environmental signal for DC-SIGN
induction [35].
DCs and macrophages are the main targets for LPS,
thus participating in the immune response to gram-negative
bacteria. It is possible that the Le epitope mimicry may con-
tribute to a diﬀerent eﬀectiveness of IL-8 and tumor necrosis
factor (TNF) secretion by peripheral blood mononuclear
leukocytes in response to H. pylori LPS. It was shown that
macrophages stimulated with H. pylori LPS of LeX or LeY
type produce cytokines more eﬀectively than those cultured
in the presence of H. pylori LPS without these determinants
[36]. The presence of LeX or LeY moieties in H. pylori LPS
promotes a production of potentially self-destructive anti-
LeX and anti-LeY IgG in patients with coronary heart disease,
seropositive for anti-H. pylori antibodies [26]. Appelmelk
et al. reported that the epitope which was most commonly
recognized by anti-LPS antibodies in the sera from H. pylori-
infected patients was the LeX blood group antigen [25].
The interaction between H. pylori L P Sa n dD C si sp o o r l y
understood. In this study, we asked whether H. pylori targets
DC-SIGN using its LPS and whether this binding occurs via
LeX and LeY determinants or not. The binding of H. pylori
to DC-SIGN may result in functional consequences espe-
cially regarding the ability of DCs to produce and secrete
cytokines. This could be of great importance for the con-
trol of H. pylori infections since both direct and indirect
stimulation of T lymphocytes by H. pylori LPS is very likely.
Furthermore, activated lymphocytes more eﬀectively control
the bacterial growth and might diminish gastric mucosa
inﬂammation by releasing cytokines, possibly of Th2 type.
Weak inﬂammatory response helps the bacteria to survive in
the host tissue.
In this study, we estimated the binding of H. pylori whole
cells and H. pylori LPS preparations with or without LeX/Y
determinants to the DC-SIGN receptor in a solid-phase
binding assay. We have also made an attempt to examine
whether LeX and LeY antigens are able to associate with na-
tive, endogenously expressed DC-SIGN. For this purpose
we adopted the THP-1 monocyte-macrophage leukemia cell
modelpretreatedwithPMA,GM-CSF,andIL-4toinducethe
expression of DC-SIGN.
2.MaterialsandMethods
2.1. Bacterial Strains. The structure of O-antigen chain and
coreoligosaccharideregionsofH.pyloristrainswithorwith-
out LeX,L e Y,a n dL e XY determinants was analysed as prev-
iously described [17, 18]. The bacteria were stored at −70◦C
in tryptic soy broth containing 10% glicerol. Before being
used in experiments the bacteria were cultured for 48h,
at 37◦C in microaerophilic conditions in the GasPack EZ
Campy Container System (Becton, Dickinson and Company,
Sparks, USA) on Columbia blood agar with 10% heat inac-
tivated foetal calf serum and washed in phosphate buﬀered
saline (PBS), pH 7.2. The expression of Le determinants on
H. pylori cells was conﬁrmed by ELISA (enzyme-linked
immunosorbent assay) using mouse monoclonal anti-LeX
(mAb anti- LeX) and anti-LeY (mAb anti- LeY) antibodies
(Merck, Darmstadt, Germany), and control antigens: syn-
thetic LeX and LeY determinants (Merck) or LeX-BSA (Dex-
tra Laboratories Ltd, Reading, UK), as previously described
[37].
2.2. H. pylori Lipopolysaccharides. The H. pylori LPS prepa-
rations were classiﬁed chemically and serologically as LeX(+),
LeY(+),L e XY(+),o rL e XY(−) [17, 18]. The H. pylori LPS was ob-
tained by the hot phenol-water extraction method after pre-
treatment of bacterial biomass with protease. The LPS crude
preparation was then treated with RNase, DNase, protein
kinase, and ultracentrifugation, as previously described [38].
2.3. The Estimation of H. pylori Whole Cells and H. pylori LPS
Binding to Soluble DC-SIGN in the Solid-Phase Assay. The
binding of H. pylori whole cells and H. pylori LPS prepara-
tions to DC-SIGN was estimated by ELISA, as recommended
by Geijtenbeek et al. [34]. The ELISA plates were coated in
triplicate with antigens: 1 × 107 bacterial cells/well, 2μg/mL
of LPS, and 1μg/mL of synthetic LeX-BSA determinants
(Dextra Laboratories Ltd) in the carbonate buﬀer pH 9.6,
18h, 4◦C. After blocking (3% bovine serum albumin in PBS
supplemented with 0.05% Tween 80-PBS/BSA/Tween, 2h
at 20◦C) and washing (Tris-saline-magnesium buﬀer-TSM,Journal of Biomedicine and Biotechnology 3
pH 7.4–8.0), the plates were incubated with 1μg/well of the
recombinant DC-SIGN/Fc chimera—rhDC-SIGN/Fc (R&D
Systems, Minneapolis, USA) in TSM, 1h, 37◦C, and washed
again. The immunocomplexes were detected using anti-hu-
man IgG antibodies conjugated with HRP—horseradish per-
oxidase (Dako, Glostrup, Denmark). For color development,
chromogen o-phenylenediamine dihydrochloride (Sigma, St.
Louis, USA) was added in the concentration of 1mg/mL in
the citric phosphate buﬀer, pH 5.0, with 0.005mL of 30%
H2O2/mL. The results were expressed as OD450 values. In
each ELISA test the control wells were included for the eval-
uation of unspeciﬁc reactions. The ELISA cut-oﬀ value was
deﬁned as twice mean OD for the control wells coated with
only one type of antigen or rhDC-SIGN/Fc, incubated with
an HRP-conjugated secondary antibody and chromogen-
substrate detection solution. The cut-oﬀ OD values were in
the range of 0.1-0.2.
2.4. The Binding Speciﬁcity of H. pylori Whole Cells and H.
pylori LPS to Soluble DC-SIGN Detected in the Solid-Phase
Inhibition Assay. In order to identify the speciﬁcity of DC-
SIGN binding, the inhibition of a solid-phase binding assay
was performed using various blocking agents: mouse mono-
clonalantibodiesagainstLeX andLeY determinants,2μg/well
(Merck),lipopolysaccharidebindingprotein(LBP),2μg/well
(HyCult Biotechnology, Uden, Holland), rabbit antibodies
against the LPS core region 1:500, and fucose or galactose,
25μg/well (Sigma). These inhibitors were added into the
selected wells coated with H. pylori LPSs or LewisX-BSA and
the plates were incubated for 30min, 37◦C. After washing,
the ELISA assay was performed as previously described. Spe-
ciﬁcity of DC-SIGN binding to H. pylori whole cells was
established by pretreatment of bacterial cells (30min, 37◦C)
with monoclonal anti-LeX and anti-LeY antibodies, LBP and
fucose or galactose. The binding speciﬁcity was estimated by
comparing OD values for the ELISA assay without inhibitors
to the results obtained in the assay developed using inhi-
bitory agents.
2.5. THP-1 Cell Culture. The acute monocytic leukemia cell
line THP-1 was obtained from the American Type Culture
Collection (ATCC, Rockville, MD). Cells were cultured in
RPMI 1640 medium with 10% foetal calf serum and main-
tained at 5 × 105 cell/mL. THP-1 cell diﬀerentiation was
induced by the addition of phorbol myristate acetate (PMA)
in the ﬁnal concentration of 50nM. After 24h incubation,
a granulocyte-macrophage colony-stimulating factor—GM-
CSF (25ng/mL)—either alone or in combination with inter-
leukin 4-IL-4 (10ng/mL) was added, and the cell cultures
were continued for 5 days, at 37◦C, 5% CO2.F o rs u b s e q u e n t
analysis, diﬀerentiated THP-1 cells were detached from cul-
ture plates by incubation with PBS 5mM EDTA on ice.
2.6. The Immunoﬂuorescence Assay for the Detection of DC-
SIGNExpressiononTHP-1CellsandItsBindingtoSolubleLeX
orLeY Determinants. Thephenotypicanalysisofthecellswas
carried out by an indirect immunoﬂuorescence assay using
mouse monoclonal anti-DC-SIGN antibodies and FITC-
conjugated polyclonal sheep antibodies against mouse im-
munoglobulins. The ﬁrst incubation was performed in the
presence of 1% inactivated sheep serum solution in PBS. The
ﬂuorescenceintensitywasestimatedusingtheVictor2reader
(Wallac,Oy,Turku,Finland)andcellimagingwasperformed
using JuLI Smart ﬂuorescent cell analyzer (Digital Bio
Technology, Boston, USA). To verify whether DC-SIGN on
THP-1 cells binds to LeX or LeY determinants, the cells
were incubated with soluble, synthetic LeX or LeY,2 0μg/mL
(Merck), and then treated with mouse monoclonal anti-
bodies against DC-SIGN, followed by the treatment with
FITC-conjugated polyclonal sheep antibodies to mouse im-
munoglobulins.
TheinteractionofsolubleDC-SIGN(R&DSystems)with
LeX or LeY determinants expressed on the surface of THP-1
cells was also estimated. The ﬂuorescence values for the
THP-1 cells incubated with mouse mAb anti-LeX or anti-LeY
detectedwithFITC-labeledsheepanti-mouse IgGwerecom-
pared to the ﬂuorescence intensity values obtained in the
inhibition assay where DC-SIGN was used before the in-
cubation with mouse mAb anti-LeX or anti-LeY and then
with FITC-labeled sheep anti-mouse IgG.
3. Results
3.1. Binding of H. pylori Whole Cells to rhDC-SIGN/Fc. The
solid-phase binding assay results presented in Figure 1 show
that H. pylori whole cells containing LPS with LeX,L e Y or
LeXY determinants bound to rhDC-SIGN/Fc. The binding
of H. pylori whole cells expressing LeX to rhDC-SIGN was
inhibited by mAb anti- LeX and fucose but not with anti- LeY
mAb.BycomparisonthebindingofH.pyloriwholecellswith
LeY expression was inhibited by anti- LeY mAb and fucose
butnotwithanti-LeX mAb.ThebindingofH.pyloriLewisXY
positive whole cells to DC-SIGN was partially decreased
when anti-LeX mAb and anti-LeY mAb were used separately
and almost completely when anti-LeX and anti-LeY mAb
were used simultaneously. The binding was successfullyinhi-
bited by fucose moieties as well. In addition we showed that
bacteria bearing LPS without LeXY determinants were also
able to bind rhDC-SIGN. The binding aﬃnity of H. pylori
whole cells which do not carry LeX and LeY determinants to
rhDC-SIGN was inhibited neither with mAb anti-LeX and
mAb anti-LeY nor with polyclonal antibodies to the core re-
gion of LPS. Similarly, the LBP molecule which binds LPS
via lipid A had no inhibitory eﬀect. The binding of H.
pylori whole cells producing LPS without LeXY determinants
to rhDC-SIGN/Fc was successfully inhibited by galactose
(Figure 2).
3.2. Speciﬁcity of H. pylori LPS Binding to rhDC-SIGN. The
results presented in Figure 2 show that H. pylori-rhDC-
SIGN/Fc binding occurs via LPS. The inhibition of LPS-
rhDC-SIGN/Fc interaction with mAb anti-LeX and/or mAb
anti-LeY orfucoseindicatedthatrhDC-SIGN/FcboundtoLe
determinants in LPS molecules: LeX,L e Y, or both in fucose-
dependent manner. The role of LeX determinants in the
interaction with DC-SIGN was conﬁrmed in the solid-phase4 Journal of Biomedicine and Biotechnology
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Figure 1: The binding of H. pylori whole cells positive or negative for LeX,L e Y,o rL e XY determinants with a soluble DC-SIGN receptor. The
binding estimated by the solid-phase assay (grey bars). The speciﬁcity of binding estimated by the solid-phase inhibition assay (black bars).
binding and binding inhibition assays using the plates coated
with synthetic LeX-BSA and several blocking agents: anti-
LeX mAb, anti-LeY mAb, or fucose. We showed that the LPSs
without LeX or LeY determinants also eﬀectively bound to
rhDC-SIGN/Fc. The interaction via the core region or lipid
A of the LPS was rather excluded due to the lack of the inhi-
bitory eﬀect when anti-LPS core region antibodies or LBP
were used, respectively. The binding of puriﬁed H. pylori LPS
without LeX and LeY determinants was blocked by galactose,
indicating that this sugar moiety in H. pylori LPS lacking LeX
or LeY determinants mediated the binding of LeX/Y negative
LPS to rhDC-SIGN.
3.3. Detection of DC-SIGN on the Surface of THP-1 Cells and
ItsBindingtoSoluble LeX andLeY DeterminantsintheIndirect
Immunoﬂuorescence Assay. The surface expression of DC-
SIGN on THP-1 cells was induced by PMA, GM-CSF, and
IL-4, treatment. We veriﬁed this by quantitative ﬂuorescence
measurement of THP-1 cells labeled with mouse anti-DC-
SIGN mAb and then with FITC-conjugated sheep antibodies
against mouse Igs before and after PMA, GM-CSF, and IL-4
treatment. The unspeciﬁc ﬂuorescence intensity of control
cells, which were not treated with PMA, GM-CSF and IL-4
reached the value of 240 RFU, whereas the unspeciﬁc ﬂuo-
rescence intensity of PMA, GM-CSF and IL-4 treated cells
was equal to 545 RFU (Figures 3(a), 3(b)). The ﬂuorescence
of nondiﬀerentiated THP-1 cells labeled with anti-DC-SIGN
mAb reached 900 RFU versus 4400 RFU for diﬀerentiated
THP-1 cells (Figure 3(c), 3(d)). Pretreatment of diﬀerenti-
ated THP-1 cells with synthetic LeX, before the incubation
with anti-DC-SIGN antibodies, diminished the ﬂuorescence
emission of the cells to 1270 RFU (Figure 3(e)) which ac-
countedfor70%decreaseinﬂuorescenceintensity. Similarly,
pretreatment of diﬀerentiated THP-1 cells with synthetic LeY
before the incubation of the cells with anti-DC-SIGN mAb,
diminished the ﬂuorescence emission to 2800 RFU which
constitute for 36% inhibition (Figure 3(f)).
3.4. Detection of LeX and LeY Determinants on the Surface of
THP-1 Cells and Their Binding to Soluble DC-SIGN in the
Indirect Immunoﬂuorescence Assay. The unspeciﬁc ﬂuores-
cenceintensityofnondiﬀerentiatedanddiﬀerentiatedTHP-1
cells is shown on Figures 4(a) and 4(b), respectively. The
presence of LeX determinants on the surface of THP-1 cells
was veriﬁed by the preincubation of the cells with mouse
mAb anti-LeX followed by the treatment of the cells with
FITC-conjugated antibodies against mouse Igs. The ﬂuores-
cence intensity of the cells treated in this way was equal to
2388 RFU (Figure 4(c)). By comparison, the pretreatment of
the cells with soluble DC-SIGN before the incubation with
amousemAbanti-LeX andwithFITC-conjugatedantibodies
against mouse Igs caused a decrease in the ﬂuorescenceJournal of Biomedicine and Biotechnology 5
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intensity from 2388 RFU to 1282 RFU (46% reduction)
(Figure 4(d)).TheLeY expositiononthesurfaceofTHP1was
visualized by treatment of the cells with anti-LeY mAb fol-
lowedbytheincubationwithsecondaryantibodyconjugated
with FITC. The ﬂuorescence intensity of THP-1 cells stained
with anti- LeY mAb was equal to 913 RFU (Figure 4(e)) and
was not diminished (971 RFU) after treatment of the cells
with soluble DC-SIGN (Figure 4(f)).
4. Discussion
Geijtenbeek et al. demonstrated that DC-SIGN is exclusively
expressed on DCs and it mediates the interaction between
DCs and resting T cells via ICAM-3, which is required for
DCs-T-cell clustering and for DC-induced proliferation of
resting T cells [34]. Several pathogens are able to target DC-
SIGN and modulate DC functions and, due to this, escape
immune response of the host [39–42]. Little attention was
paid to the role of DCs in H. pylori infection, and how this
pathogen is able to persistently colonize so many hosts is
poorly understood. DC-SIGN recognizes both internal
branched mannose residues and terminal di-mannoses, α-1-
3andα-1-4fucosylatedglycanstructuresaswellascertainN-
acetyloglucosamine containing molecules on self proteins/or
pathogens [43–46]. It was suggested that H. pylori binds to
DC-SIGN via common pathogen recognition patterns such
as high mannose and/or Lewis carbohydrates [33]. The pres-
ence of Lewis epitopes in the O-speciﬁc region of LPS pos-
sibly enables these bacteria to omit the immune responses,
resulting in the phenomenon of antigenic mimicry. It was
assumed that the diﬀerences in H. pylori binding aﬃnity to
the DC-SIGN receptor is determined by the Le phase varia-
tion. This ability of H. pylori might allow the bacteria to
modulate the host immune responses and in consequence
contributes to the persistent character of this infection [33].
The results obtained in this study indicate that H. pylori
whole cells with antigenic LeX and/or LeY determinants bind
to the recombinant DC-SIGN receptor. Similarly, H. pylori
LPS of LeX,L e Y,L e XY type was involved in rhDC-SIGN/Fc
binding. The fucose residues present in the structure of LeX
and LeY determinants were responsible for binding speci-
ﬁcity of H. pylori cells containing LPS of LeX,L e Y,o rL e XY to
DC-SIGN receptor. This was shown in binding inhibition
assay with monoclonal anti-LeX and/or anti-LeY antibodies,
and fucose. Bergman et al. demonstrated that DC-SIGN rec-
ognizes H. pylori and the binding of H. pylori whole cells or
puriﬁed LPS to DC-SIGN was blocked with anti-DC-SIGN
antibodies, mannan, or by ethylene glycol tetraacetic acid
(EGTA)-Ca2+ chelating agent. H. pylori expressing LeY or
short chains of LeX (monomeric LeX up to (LeX)4), but not
polymeric LeX, were able to bind DC-SIGN. Double knock-
out H. pylori mutants without α-3-fucosyltransferases FutA
and FutB unable to produce LeY and monomeric LeX did not
bindDC-SIGN.Alsostericorganizationofthesugarresidues
of Le antigens inﬂuences their binding aﬃnity to DC-SIGN
[33].
In this study H. pylori whole cells and LPS preparations
without LeX and LeY determinants were also found to be able6 Journal of Biomedicine and Biotechnology
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to bind DC-SIGN. The binding was successfully inhibited
with galactose but not with anti-LeX/Y or anti-LPS core
regionantibodies.Guoetal.showedthatLeX oligosaccharide
primarily binds to DC-SIGN through the fucose moieties.
However, galactose is involved in the stabilization of this
interaction [44]. The H. pylori LeXY negative strain used in
this study contained a galE gene encoding UDP-galactose 4-
epimerase, which mediates the incorporation of galactose in
the O-side chain of LPS. To elucidate the role of galactose in
H. pylori LPS binding to DC-SIGN, the construction of gale-
deﬁcient mutant would be of major beneﬁt. Recently, Klena
et al. demonstrated that only E. coli strains bearing the com-
plete core region (without O-antigen) are able to mediate
binding to DC-SIGN and, in consequence, further phago-
cytosis of bacteria by macrophages [47]. Previous studies
demonstrated that DC-SIGN, besides binding to mannose
and fucose, can also interact with glucose, α-1,4-diglucosyl
(maltose) structures, and galactose [48]. The binding of
galactose to mannose-speciﬁc C-type carbohydrate recogni-
tion domains (CRDs) can occur through interactions with
the C-1 and C-2 hydroxyl groups of the free sugar [49].
Recently α-glucans were identiﬁed as new ligands for DC-
SIGN [50].
DC-SIGN expression is induced de novo during the gen-
erationofmonocyte-derivedcellsandisnormallyconsidered
asaDC-speciﬁcphenotypicmarker.However,DC-SIGNwas
also detected on synovial, placenta, and alveolar macro-
phages [34]. The expression of DC-SIGN depends on IL-4
which drives monocyte/macrophages into the “alternative
activation”pathwayorresultsinthegenerationofmonocyte-
derived dendritic cells if combined with GM-CSF. It was
shown that leukemic THP-1 cells, widely used as a model
for monocyte-macrophage diﬀerentiation, express very low,
basal amounts of DC-SIGN and that expression of DC-SIGN
in THP-1 cells is regulated during diﬀerentiation induced by
PMA, GM-CSF, and IL-4 [51]. These results demonstrate
that DC-SIGN is a marker for both DCs and alternatively
activated macrophages and is present on THP-1 cells, which
may be considered a useful cellular system to characterize the
pathogen binding capacities. In this study, we asked whether
THP-1cellswiththesurfaceexpressionofDC-SIGNinduced
by PMA, GM-CSF, and IL-4 can bind to synthetic LeX and
LeY determinants. Considering the fact that the role of DCs
and DC-SIGN receptors in the course of H. pylori infections
is poorly understood, the detection of interactions between
H. pylori antigens and DC-SIGN, especially in the context
of LeX and LeY determinants in H. pylori LPS structure,
could be of great importance. This study was focused on the
development of a cellular model to estimate the interactions
betweenH.pyloriexpressingLeX and/orLeY antigensandthe
DC-SIGN receptor in a solid-phase assay. The upregulation
of the DC-SIGN receptor on the surface of THP-1 cells was
induced by the stimulation of the cells with PMA, GM-CSF,
and IL-4 as recommended by Puig-Kr¨ oger et al. and assessed
quantitativelybyanimmunoﬂuorescenceassay,usingmono-
clonal anti-DC-SIGN antibodies and FITC-conjugated anti-
mouse Igs [51]. Our results demonstrated that DC-SIGN-
like receptor is present on the surface of THP-1 cells and that
this receptor is able to bind synthetic LeX and LeY determi-
nants. This enables the assessment of molecular eﬀects of the
H. pylori-DC-SIGN interactions via Le determinants using
the THP-1 cellular model. Previously, Perez-Perez et al.,
using PMA diﬀerentiated THP-1 cells, showed that the lipid
Afr omH.pyloriLPShasalowabilitytomediatemacrophage
activation [52]. We expect that the in vitro THP-1 cellular
model could help to elucidate how leukemic cells, especially
of monocytic lineage, respond to H. pylori polysaccharide
stimuli, regarding the expression of HLA-DR, CD40, CD80
and CD86, as well as the antigen uptake ability and potency
in inducing allogenic T-cell proliferation. This cellular tool
couldrevealnewfactsregardingimmuneresponseelicitedby
H. pylori compounds, especially in the context of its activity
as a bacterial carcinogen classiﬁed to IInd group. Recently,
Chan et al. showed that Ganoderma lucidum polysaccharides
can induce transformation of THP-1 cells into dendritic cells
with an immune-stimulatory function [53]. It was also
demonstrated that, apart from α1β2 integrin, DC-SIGN on
macrophages and DCs is an additional ligand for the lym-
phocyte ICAM-3 molecule which mediates the contact
between T cells and antigen-presenting cells. ICAM-3 also
assists in the interaction of granulocytes with DC-SIGN of
DCs [54].
We also asked whether the expression of LeX and LeY
determinants on the surface of THP-1 cells makes this model
suitable for the estimation of interactions with soluble DC-
SIGN.
In this study we demonstrated binding of soluble DC-
S I G Nr e c e p t o rw i t hL e X determinants on THP-1 cells. By
comparison using this model we could not show successful
binding of soluble DC-SIGN with LeY due to low expression
of such determinants on THP-1 cells. In this case the THP-1
cellular model may selectively mimic the interactions be-
tween surface-exposed LeX determinants and DC-SIGN
molecule thus it opens new experimental possibilities. On
the other hand, the results demonstrating the presence of a
DC-SIGN-like receptor on the surface of THP-1 cells show
that this cellular model can be used for the assessment of
molecular eﬀects due to H. pylori-DC-SIGN interactions via
surface exposed or soluble Lewis compounds, which can be
released during bacterial cell lysis in the inﬂammatory milieu
of H. pylori colonized gastric mucosa. This idea correlates
with the results obtained in the solid-phase assay showing
that LeX,L e Y,a n dL e XY determinants on H. pylori whole cells
and H. pylori LPS preparations are involved in binding with
DC-SIGN.
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